Company / Operating Cash Flow per Share
Opus Genetics, Inc. Operating Cash Flow per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.81
FY2025
5-year range
-$1.03 / $0.69
FY2021-FY2025
Trend
-1646.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -1647% YoY in FY2025, a notable deviation from the 6-year average annual change of -445%.
Based on SEC 10-K filings.
-0.81 in FY2025.
Declined from $0.69 to $-0.81 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 1646.6% year-over-year.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.81 | -1646.6% |
| FY2024 | -$0.05 | -106.8% |
| FY2023 | $0.69 | +166.8% |
| FY2022 | -$1.03 | -64.6% |
| FY2021 | -$0.62 | -1026.9% |
| FY2013 | -$0.06 | +9.4% |
| FY2011 | -$0.06 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026